Protecting the heart: biological targets and clinical strategies

Alberto R De Caterina1, Florim Cuculi, Adrian P Banning

  • 1Oxford University Hospitals, Headley Way, Oxford OX3 9DU, United Kingdom.

Insights

Restoring blood flow to the heart can paradoxically cause further damage, known as ischemia-reperfusion (IR) injury. This review explores clinical assessments and strategies to protect the heart from this reperfusion injury.

Area of Science:

  • Cardiovascular Pathophysiology
  • Myocardial Ischemia-Reperfusion Injury

Background:

  • Ischemic cardiomyopathy involves complex myocardial damage.
  • Restoring blood flow (reperfusion) can paradoxically worsen myocardial injury.

Purpose of the Study:

  • To highlight the clinical relevance of ischemia-reperfusion (IR) injury.
  • To review clinical assessment methods for IR injury.
  • To summarize promising pharmacological and non-pharmacological protective strategies.

Main Methods:

  • Review of existing literature on IR injury.
  • Focus on molecular events during myocardial reperfusion.
  • Analysis of clinical translation potential for protective strategies.

Main Results:

  • Identified three key components of IR injury: cardiomyocyte, vascular, and inflammatory damage.
  • Emphasized the growing interest in IR injury protection techniques.
  • Highlighted the need for strategies to mitigate reperfusion-induced damage.

Conclusions:

  • IR injury significantly complicates ischemic cardiomyopathy treatment.
  • Clinical assessment and protective strategies are crucial for improving outcomes.
  • Further research into pharmacological and non-pharmacological interventions holds promise for clinical practice.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...